tirzepatide and bimagrumab A drug called apitegromab may help to preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The Choosing Between Tirzepatide and Semaglutide

When taking tirzepatide, its important to understand how alcohol may affect you depending on the dosage of the medication

If the answer to both is no, they will continue to up-titrate the dose by 2.5 mg every 4 weeks until reaching the next weight loss maintenance dose

The Healthon Weight Loss Program offers two highly effective GLP-1 medications: Semaglutide (Generic Ozempic/Wegovy): A GLP-1 receptor agonist, FDA-approved for weight management and type 2 diabetes

00:05:36 No, but we presented our first findings about this at the diabetes meeting in Madrid in 1985

These benefits occur quickly following treatment initiation, suggesting that GLP-1 medicines may reduce cardiovascular events, at least in part, through weight loss-independent mechanisms